On June 16, 2017, Guangdong Runke Bioengineering Co., Ltd. held the joint-stock company founding meeting. All shareholders, directors, supervisors, and executives of the company attended the meeting. Ms. Chen Xuan, the controlling shareholder and chairman of the board, sincerely delivered a speech: With the development of the company's strategy, Runke continues to grow and develop. In order to make Runke become a century-old store and a listed public company, the founding meeting was initiated by new and old shareholders, and the company changed its name to "Guangdong Runke Bioengineering Co., Ltd.", officially beginning the company's journey towards the capital market.
Guangdong Runke Bioengineering Co., Ltd. was founded in May 2000 in Shantou, Guangdong. It is a national high-tech enterprise that applies modern bioengineering technology to research, develop, and produce human health products derived from marine microalgae. Since its establishment, the company has been focusing on the research and development, production, and sales of high-end food fortifiers, using bioengineering technology to cultivate marine microalgae rich in DHA (docosahexaenoic acid) and breed cells with high content of ARA (arachidonic acid), and extract DHA and ARA nutritional fortifiers respectively. The main products are DHA algal oil, DHA powder, ARA oil, ARA powder, and DHA+ARA mixed powder. DHA belongs to the N-3 series of polyunsaturated fatty acids, promoting the growth of brain cells and the formation of neural networks, enhancing intelligence and nerve health. ARA belongs to the N-6 series of polyunsaturated fatty acids, promoting physical development.
The company's development goal is to further develop the marine microalgae and microbiology industry by utilizing bioengineering technology, and to become a leading supplier of nutritional enhancers, nutritional raw materials, and nutritional products in China's healthy food industry. It aims to serve human health with high-quality health products and to build Runke into an internationally renowned modern biotechnology enterprise.
